LGALS3 and Huntington disease: In addition, several studies showed that Gal-3 levels in brain and plasma were higher in experimental models and patients with Huntington’s disease (HD) (Siew et al., 2019) and ALS (Zhou et al., 2010; Yan J. et al., 2016) than in healthy controls and correlated with disease severity.